The “Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by…
Category: Primers
Veterinary Vaccine Global Market Forecast Report: A $19.86 Billion Market by 2033, Registering 7.3% CAGR During 2023-2033
The “Veterinary Vaccine Market – A Global and Regional Analysis: Focus on Type, Disease, Technology, Route of…
MyFitnessPal Spills the Beans: Americans Don’t Know Enough About Fiber and Have Bathroom Anxiety
Roses are red, violets are blue, almost half of Americans don’t know how their fiber intake…
400,000 WATS(3D) Procedures Marks Significant Milestone In Advancing Patient Care & Saving Lives
CDx Diagnostics, Inc. today announced that it has received its 400,000thWATS3D specimen. WATS3D, the company’s proprietary diagnostic platform…
Home Instead hiring 30,000 care professionals to support aging population
Many Home Instead franchises across America are experiencing a dramatic increase in service inquiries from concerned…
NYU Langone Officially Opens State-of-the-Art Ambulatory Care Center in Former Garden City Bloomingdale’s Building, its Largest on Long Island
Expanding its award-winning health network, NYU Langone Health this month opened its largest ambulatory care center on Long…
Medline to launch Lisfranc System at ACFAS 2024 Annual Scientific Conference
Attendees at this year’s American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference in Tampa,…
Mindray Partners with Aegle Medical Solutions to Expand its Non-Invasive Liver Care Offerings to the U.S. Market
Mindray North America, a global leader and developer of healthcare technologies and solutions for patient monitoring, anesthesia, and ultrasound announced…
United States Vaccine Market Analysis Report 2023: Market is Projected to Increase by 47% to $35.1 Billion in 2030
The “2023 U.S. Vaccine Market Report” report has been added to ResearchAndMarkets.com’s offering. The U.S. vaccine market is valued at $23.8…
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan
The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib)…